文献速递头颈MR

扩散加权磁共振成像评估唾液腺功能用于放射性口干随访

Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia.
PubMed 文献 · Korean J Radiol · 2018-06-14

本研究纳入23例接受腮腺保护性放疗的鼻咽癌患者,于放疗前、放疗后1周及1年行DW-MRI评估唾液腺功能。放疗后1周腮腺和颌下腺ADC均升高,放疗后1年腮腺ADC下降而颌下腺无显著变化;13例患者口干改善,多因素分析显示腮腺剂量、颌下腺ADC、腮腺最大ADC及达峰时间共4个因素与口干改善显著相关。结论认为ADC值是唾液腺功能障碍的敏感指标,DW-MRI可能有助于无创预测放射性口干的严重程度。

要点

  • 放疗后1周腮腺与颌下腺ADC均较放疗前升高(均p<0.001)。
  • 放疗后1年腮腺ADC较1周时下降(p<0.001),颌下腺ADC无显著变化(p=0.581)。
  • 放疗后1周颌下腺ADC(OR=3.295)、腮腺最大ADC(OR=0.474)和达峰时间(OR=0.729)与口干改善相关。

核心结论

  • ADC值是唾液腺功能障碍的敏感指标,DW-MRI可能有助于无创预测放射性口干的严重程度。

研究设计与样本

  • 研究纳入23例接受腮腺保护性放疗的鼻咽癌患者,于放疗前、放疗后1周及1年分别行DW-MRI评估唾液功能,获取刺激下腮腺最大ADC(pADCmax)和腮腺ADC达峰时间(pTmax),采用多因素分析分析与放射性口干严重程度相关的因素。

关键影像表现/征象

  • 放疗前腮腺ADC为1.26 ± 0.10 × 10-3 mm2/s,颌下腺ADC为1.32 ± 0.07 × 10-3 mm2/s。
  • 放疗后1周腮腺ADC升至1.75 ± 0.16 × 10-3 mm2/s(p < 0.001),颌下腺ADC升至1.70 ± 0.16 × 10-3 mm2/s(p < 0.001)。
  • 放疗后1年腮腺ADC降至1.57 ± 0.15 × 10-3 mm2/s(p < 0.001),颌下腺ADC为1.69 ± 0.18 × 10-3 mm2/s(p = 0.581)。

诊断标准与关键数值

  • 腮腺最大ADC(pADCmax)预测口干改善的OR为0.474(p = 0.024)。
  • 腮腺ADC达峰时间(pTmax)预测口干改善的OR为0.729(p = 0.017)。
  • 颌下腺ADC预测口干改善的OR为3.295(p = 0.013)。
  • 腮腺剂量预测口干改善的OR为0.639(p = 0.009)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the value of diffusion-weighted magnetic resonance imaging (DW-MRI) as a noninvasive tool to assess salivary gland function for follow-up of patients with radiation-induced xerostomia.

MATERIALS AND METHODS: This study included 23 patients with nasopharyngeal carcinoma who had been treated with parotid-sparing radiotherapy (RT). Salivary function was assessed by DW-MRI pre-treatment and one week and one year post-RT, respectively. The maximum apparent diffusion coefficient (ADC) of parotid glands (pADCmax) and the time to peak ADC of parotid glands (pTmax) during stimulation were obtained. Multivariate analysis was used to analyze factors correlated with the severity of radiation-induced xerostomia.

RESULTS: The ADCs of parotid and submandibular glands (1.26 ± 0.10 × 10-3 mm2/s and 1.32 ± 0.07 × 10-3 mm2/s pre-RT, respectively) both showed an increase in all patients at one week post-RT (1.75 ± 0.16 × 10-3 mm2/s, p < 0.001 and 1.70 ± 0.16 × 10-3 mm2/s, p < 0.001, respectively), followed by a decrease in parotid glands at one year post-RT(1.57 ± 0.15 × 10-3 mm2/s, p < 0.001) but not in submandibular glands (1.69 ± 0.18 × 10-3 mm2/s, p = 0.581). An improvement in xerostomia was found in 13 patients at one year post-RT. Multivariate analysis revealed 4 significant predictors for the improvement of xerostomia, including dose to parotid glands (p = 0.009, odds ratio [OR] = 0.639), the ADC of submandibular glands (p = 0.013, OR = 3.295), pADCmax (p = 0.024, OR = 0.474), and pTmax (p = 0.017, OR = 0.729) at one week post-RT.

CONCLUSION: The ADC value is a sensitive indicator for salivary gland dysfunction. DW-MRI is potentially useful for noninvasively predicting the severity of radiation-induced xerostomia.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Ou D, Gu Y, et al. Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia. Korean J Radiol. 2018. PMID: 29962882. doi:10.3348/kjr.2018.19.4.758

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。